http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01128997-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 1988-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58be455d1ac60f3605b73811c98b9179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef8674ea2eb81382e4d43803ab0e316f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6905eaa630b0124de8a57cdd7249dd94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc42f4b1178616da1d4faec30c8154e0
publicationDate 1989-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H01128997-A
titleOfInvention Amino acid ester and its production
abstract NEW MATERIAL: The compd. of formula I [(n) is 1 or 2; R is H, a substituted 1-21C aliphatic group, a (substituted) 3-20C alicyclic group, a (substituted) 6-12C aliphatic group, a (substituted) 3-20C alicyclic group, a (substituted) 4-20C alicyclic-aliphatic group or the like; R 2 and R 3 are H, a (substituted) 1-21C aliphatic group, a (substituted) 3-20C alicyclic group, a (substituted) 6-12C aromatic group or the formula II [R 4 is H, a 1-6C aliphatic group or the like), etc., where at least either R 3 or R 4 is the formula II]. n EXAMPLE: 5-Methyl-1,3-dioxoleci-2-one-4-ylmethyl2-[N-(1S-ethoxycarbonyl-3- phenylpropyl)-S-alanyl]-(1S,3S,5S)-2-azabicyclo[3,3,0]octane-3-carboxylate. n USE: It is useful as the prodrugs of angiotensin conversion enzyme inhibitors, agents for treating hypertension, agents for treating Alzheimer's diseases or the like. n PREPARATION: A compd. of formula III is reacted with a compd. of formula IV (X is Br or the like) under the conditions of nucleophilic substitution reaction. n COPYRIGHT: (C)1989,JPO
priorityDate 1987-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268

Total number of triples: 32.